Continuing Education
Updates in Breast Cancer: Antibody-Drug Conjugates and Cyclin-Dependent Kinase Inhibitors
Best Suited For: Pharmacist, Pharmacy Technician
CE Credits: 1.0 hours
Related Topics: Antibody Drug Conjugates (ADC)
Activity Description
This activity is designed to provide updated information on recent publications and clinical trials involving the use of CDK4/6 inhibitors and antibody-drug conjugates (ADCs) in breast cancer. This activity will provide information on new indications of CDK4/6 inhibitors based on the PATINA trial.
It will also provide information on new indications of the ADCs sacituzumab govitecan, fam-trastuzumab deruxtecan, and datopotamab deruxtecan based on the ASCENT-03, ASCENT-04, DESTINY Breast-05, DESTINY Breast-09, and TROPION Breast-02 trials. Additionally, information on safety of the covered medications will be reviewed.
CE Credit: 1.0 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Describe changes to the role of CDK4/6 inhibitors in hormone receptor (HR)-positive/HER2-positive breast cancer.
- Characterize the expanding role of fam-trastuzumab deruxtecan-nxki across HER2-positive breast cancer.
- Discuss the efficacy and safety of Antibody Drug Conjugates (ADCs) in metastatic triple-negative breast cancer.
- Recognize clinically significant adverse events and intervention strategies associated with novel ADCs and CDK4/6 inhibitors.
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, eligible continuing education credit will be submitted to the appropriate accrediting body. Pharmacist and pharmacy technician credit will be reported to ACPE and reflected in your CPE Monitor profile within 24 hours. Reporting timelines for other healthcare professions may vary by accrediting body or state board.
CE information for nurses, nurse practitioners (NPs), and physician assistants (PAs) can be found here.
